T. Rowe Price Investment Management, Inc. Twist Bioscience Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding TWST
# of Institutions
270Shares Held
67.2MCall Options Held
118KPut Options Held
40.2K-
Artisan Partners Limited Partnership Milwaukee, WI5.89MShares$283 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$279 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.6MShares$268 Million2.28% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$260 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.58MShares$172 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.7B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...